New hope for brain fog in schizophrenia: drug trial targets memory and focus
Symptom relief
Recruiting now
This study tests an experimental drug called KYN-5356 to see if it can help with thinking and memory problems that often come with schizophrenia. About 150 adults with stable schizophrenia will take either a low, medium, or high dose of the drug or a placebo daily for 28 days whi…
Phase: PHASE2 • Sponsor: Kynexis B.V. • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC